se of Trypsin and Chymotrypsin tablet in Injuries
Not Applicable
- Conditions
- Health Condition 1: S00-T88- Injury, poisoning and certain other consequences of external causes
- Registration Number
- CTRI/2024/01/061594
- Lead Sponsor
- Torrent Pharmaceuticals Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1) Male or female patients of 18 years or above
2) Patients with surgical or non-surgical injury or wound and treated with oral trypsin:chymotrypsin
Exclusion Criteria
Clinical case histories without patient ‘identifiers’ (viz. Name as Initials, Age, Gender, Height, Weight or BMI) and baseline scores for pain, edema or inflammation.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety assessment for very common Adverse Drug Reaction.Timepoint: From baseline Day 0 to 4 weeks
- Secondary Outcome Measures
Name Time Method 1) Use of resucue medication as NSAID or Acetaminophen <br/ ><br>2) Treatment choice for any class of compounds as initial or add-on therapy <br/ ><br>3) Physicians global assessment on effectiveness and tolerabilityTimepoint: From baseline Day 0 to 4 weeks